Skip to main content

Table 1 Clinicopathologic characteristics of pure ductal carcinoma in situ (DCIS) and DCIS with microinvasion

From: Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast

Clinicopathologic characteristics

Pure DCIS (n = 231)

DCIS with microinvasion (n = 81)

p value

Age (years)

Median (range)

47 (25–88)

48 (26–76)

0.556

Extent of DCIS (cm)

Median (range)

2.5 (0.4–12.2)

4.2 (0.9–14.5)

< 0.001

Nuclear grade

Low

16 (6.9)

2 (2.5)

< 0.001

Intermediate

129 (55.8)

20 (24.7)

 

High

86 (37.2)

59 (72.8)

 

Comedo-type necrosis

Absent

181 (78.4)

30 (37.0)

< 0.001

Present

50 (21.6)

51 (63.0)

 

ER

Negative

30 (13.0)

42 (51.9)

< 0.001

Positive

201 (87.0)

39 (48.1)

 

PR

Negative

44 (19.0)

47 (58.0)

< 0.001

Positive

187 (81.0)

34 (42.0)

 

HER2

Negative

196 (84.8)

43 (53.1)

< 0.001

Positive

35 (15.2)

38 (46.9)

 

Ki-67 index

< 10%

171 (74.0)

30 (37.0)

< 0.001

≥ 10%

60 (26.0)

51 (63.0)

 

P53

Negative

201 (87.0)

51 (63.0)

< 0.001

Positive

30 (13.0)

30 (37.0)

 
  1. p values were calculated by the Mann-Whitney U test and chi-square or Fisher’s exact test. Numbers in parentheses indicate column percentage
  2. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2